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Severe sepsis and septic shock are life-threaten-
ing disorders. Team work with timely resuscita-
tion is the cornerstone of management of septic
shock.1,2 It takes time and resource utilization to
implement an integrated sepsis treatment proto-
col.3–6 The prevalence of severe sepsis is about
2.26 cases per 100 hospital discharges, and 68%
of patients need intensive care.7,8 The mortality
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Background/Purpose: Severe sepsis and septic shock are life-threatening disorders. Integrating treatments
into a bundle strategy has been proposed to facilitate timely resuscitation, but is difficult to implement.
We implemented protocol-driven therapy for severe sepsis, and analyzed retrospectively the key process
indicators of mortality in managing sepsis.
Methods: Continuous quality improvement was begun to implement a tailored protocol-driven therapy
for sepsis in a 24-bed respiratory intensive care unit (RICU) of Taichung Veterans General Hospital from
January 2007 to February 2008. Patients, who were admitted to the RICU directly, or within 24 hours,
were enrolled if they met the criteria for severe sepsis and septic shock. Disease severity [Acute Physiology
and Chronic Health Evaluation (APACHE) II and lactate level], causes of sepsis, comorbidity and site of
sepsis onset were recorded. Process-of-care indicators included resuscitation time (Tr-s), RICU bed avail-
ability (Ti-s) and the ratio of completing the elements of the protocol at 1, 2, 4 and 6 hours. The structure
and process-of-care indicators related to mortality at 7 days after RICU admission and at RICU discharge
were identified retrospectively.
Results: Eighty-six patients (mean age, 71 ± 14 years; 72 men, 14 women; APACHE II, 25.0 ± 7.0) were 
enrolled. APACHE II scores and lactate levels were higher for mortality than survival at 7 days after RICU
admission (p<0.01). For the process-of-care indicators, Ti-s (562.2±483.3 vs.1017.3±557.8 minutes, p=0.03)
and Tr-s (60.7 ± 207.8 vs. 248.5 ± 453.1 minutes, p = 0.07) were shorter for survival than mortality at 7 days
after RICU admission. The logistic regression study showed that Tr-s was an important indicator. The ratio
of completing the elements of protocols at 1, 2, 4 and 6 hours ranged from 70% to 90% and was not 
related to mortality.
Conclusion: Protocol-driven therapy for sepsis was put into clinical practice. Early resuscitation and ICU
bed availability were key process indicators in managing sepsis, to reduce mortality. [J Formos Med Assoc
2009;108(10):778–787]
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rate for severe sepsis and septic shock ranges
from 30% to 50%.7,9 Even in recent studies,10,11
hospital mortality was 30–40% after sepsis bun-
dle implementation.12,13 Therefore, developing
protocol-driven therapy for severe sepsis and
septic shock is important.
Rivers et al have initiated the sepsis bundle,
also called early goal-directed therapy (EGDT).1
It has reduced hospital mortality by 16% (46.5%
vs. 30.5%) by intervention in the emergency de-
partment (ED) in patients with severe sepsis or
septic shock. Early resuscitation within the first 6
hours is crucial. In addition, integrated therapy
that consists of sepsis bundles must be followed.
Most of the studies about implementing EGDT
for sepsis have been initiated in EDs.1,6 However,
there are also many patients who develop septic
shock in the intensive care unit (ICU) and gen-
eral wards. From the viewpoint of ICU intensivists,
it is very difficult to translate sepsis research into
clinical practice. A comprehensive and integrated
treatment policy is needed to overcome possible
barriers that are encountered by healthcare givers
in EDs, general wards and even in ICUs. Nguyen
et al described a quality improvement feedback
method using the following quality indicators:
central venous pressure/central venous oxygen sat-
uration (CVP/ScvO2) by 2 hours; broad-spectrum
antibiotics by 4 hours; completing EGDT by 6
hours; and using appropriate steroids, and com-
pleting lactate clearance and sepsis bundles to
modify physician behavior and significantly de-
crease inhospital mortality in septic shock pa-
tients.10 However, their study did not take into
account the gaps between the ED, general wards
and ICU (i.e. resuscitation may not have been
given in a timely manner and continuously when
patients were transferred from the ED to the ICU,
or from the general ward to the ICU), or evalu-
ate compliance with the elements in the sepsis
bundles.
Key performance indicators are the measure-
ments used to help an organization to achieve its
goals. To improve the outcome of patients with
sepsis, we developed protocol-driven therapy for
severe sepsis and septic shock in the respiratory
ICU (RICU). Based on the time frame of the ele-
ments in the protocol, the structure and process-of-
care indicators were designed. Retrospectively, we
analyzed the key process indicators of mortality
during the implementation of the protocol-driven
therapy for severe sepsis. These indicators could
be applied to the total quality improvement of
managing patients with sepsis.
Patients and Methods
Creation of protocol-driven therapy for severe
sepsis and septic shock
Based on the study of EGDT, the Multiple Urgent
Sepsis Therapies (MUST) protocol and 2004 Sur-
viving Sepsis Campaign,1,2,13 we tailored the ele-
ments of sepsis therapy for the sake of feasibility
in our RICU, acceptance by staff and simplicity
in practice (Figure). Consensus for the protocol-
driven therapy was reached by doctors, nurses
and respiratory therapists in an RICU ward meet-
ing. Before implementation of the protocol, all
the staff received intensive education about the
sepsis campaign guidelines2 and how to use the
protocol-driven therapy. The protocol was intro-
duced into our clinical practices for managing
patients with severe sepsis in January 2007.
Patients
Severe sepsis or septic shock patients were admit-
ted to a 24-bed facility RICU via the ED or a gen-
eral ward. Patients who developed severe sepsis
or septic shock within 24 hours after admission
to the RICU were also included. The criteria for
severe sepsis and septic shock were defined ac-
cording to the American College of Chest Physi-
cians/Society of Critical Care Medicine Consensus
Conference.14 If the patients presented with tis-
sue hypoperfusion and systemic inflammatory
response syndrome (SIRS) caused by suspicious or
documented infection, they were diagnosed with
severe sepsis and considered eligible for protocol-
driven therapy. SIRS was defined as the presence
of at least two of the following: (1) temperature
> 38°C or < 36°C; (2) heart rate > 90 beats/min;
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(3) respiratory rate > 20 breaths/min or PaCO2
< 32 mmHg; and (4) white blood cell count
> 12,000/mm3 or < 4000/mm3. Tissue hypoper-
fusion was defined as at least one of the following:
(1) plasma lactate level ≥ 36 mg/dL or dysfunc-
tion of more than one organ; and (2) systolic
blood pressure < 90 mmHg or mean artery pres-
sure (MAP) < 65 mmHg after fluid supply of
20 mL/kg. Suspected or documented infection was
determined by the in-charge physician. Patients
aged < 18 years, those not meeting the criteria for
severe sepsis or septic shock, or those in whom
the event developed > 24 hours after they were
admitted to the RICU were excluded. We sum-
marized retrospectively the data of patients who
were treated according to the protocol. The study
was approved by the Institutional Review Board
of Taichung Veterans General Hospital, Taiwan,
and the informed consent of patients was waived.
Patients’ demographic data were recorded, in-
cluding: age; sex; Acute Physiology and Chronic
Health Evaluation (APACHE) II and plasma lac-
tate level at RICU admission; sources of sepsis;
length of ICU stay and hospital stay; and outcome
at 7 days after admission to RICU and at dis-
charge. Comorbidity was defined as follows: (1)
chronic lung disease, including chronic obstructive
pulmonary disease, asthma, interstitial lung dis-
ease, pneumoconiosis, bronchiectasis, tuberculosis-
related lung destruction and restrictive lung
disease; (2) cerebrovascular accident: stroke that
occurred more than 1 month ago; (3) chronic
renal disease (plasma creatinine > 2.0 mg/dL for
> 6 months); (4) cardiovascular disease, includ-
ing previous myocardial infarction, ischemic heart
disease, dilated cardiomyopathy and congestive
heart failure; and (5) liver disease: liver cirrhosis,
and hepatitis B and C.
Definition of structure, process-of-care and
outcome indicators
Structure indicators included the following (Table
1): (1) patient factors: age, sex, disease severity
based on APACHE II score and plasma lactate
level, cause of sepsis and comorbidity; and (2)
sites of sepsis diagnosis. T-sepsis was defined ret-
rospectively as the time point when the patient
met the criteria for protocol-driven therapy, by
chart review. T-resuscitation denoted the time
point when the patient started to receive inten-
sive fluid therapy with 500–1000 mL crystal fluid
or equivalent for 30 minutes. T-ICU denoted the
time point when the patient was admitted to 
the RICU. Process-of-care indicators included the
• T-sepsis: SIRS + suspected infection and tissue hypoperfusion
• T-resuscitation: The time starting fluid treatment with 500–1000 mL normal saline within
 30 minutes and adjusting the treatment based on CVP levels
• T-ICU: The time when the patient is admitted to the ICU
• 1 hr items: CBC/DC, PT/APTT, ABG, lactate, Cr, GPT, total bilirubin, urine analysis,
 cortisol level, CXR, bacterial cultures
• 2 hr items: CVP, monitoring ScvO2, SpO2, mean arterial pressure (MAP)
• 4 hr items: First dose of antibiotics; protective ventilator strategy
• 6 hr items: Reach the targets of CVP 8–12 mmHg; MAP 65–90 mmHg, ScvO2 > 70%, heart
 rate < 120 beat/min by inotropic agents, fluid therapy and blood transfusion
• 24 hr items: Glucose control < 150 mg/dL, plateau pressure < 30 cmH2O
• P: The ratio of patients with complete items among all enrolled patients at indicated time
T-sepsis T-resuscitation
?
T-ICU
P1 P2 P4 P6 P24
1 hr
items
2 hr
items
4 hr
items
6 hr
items
24 hr
items
Figure. Protocol design in the present study.
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following: (1) compliance with resuscitation
management: P1, P2, P4 and P6 as shown in the
Figure; (2) period from T-sepsis to T-ICU (Ti-s)
denoted bed availability in the RICU for patients
from the ED and general wards (a total of 33 pa-
tients); (3) period from T-sepsis to T-resuscitation
(Tr-s) denoted the delay in onset of resuscitation;
(4) initial MAP, CVP, pulse oximeter oxygen satu-
ration (SpO2) and ScvO2 were measured when
patients were admitted to the RICU and met the
enrolment criteria (Table 2).
Pressure-regulated volume control was applied
to patients with sepsis. A protective ventilatory
strategy was provided for all patients with acute
lung injury, according to the previous reports of
the ARDS (Acute Respiratory Distress Syndrome)
Network15 and 2004 Surviving Sepsis Campaign
guidelines,2 to keep the plateau pressure at
< 30 cmH2O. Plateau pressure was monitored
from 0 to 24 hours.
In addition, we divided our patients into two
groups according to time frame: an early phase
(from January 2007 to September 2007, n = 34)
and a late phase (from October 2007 to February
2008, n = 52). We compared all the indicators 
between the two respective phases (Table 3).
Table 1. Baseline data and outcome indicators of patients who received protocol-driven therapy*
RICU 7-day outcome RICU discharge outcome
Outcome All patients
Survival Mortality p Survival Mortality p
Demographic data
Patients 86 (100) 65 (75.6) 21 (24.4) 52 (60.5) 34 (39.5)
Age (yr) 71.7 ± 14.2 72.2 ± 13.8 70.0 ± 16.3 0.17 71.4 ± 14.3 72.2 ± 14.7 0.78
APACHE II 25.0 ± 7.0 23.4 ± 6.4 30.3 ± 6.3 < 0.01 22.7 ± 6.5 28.6 ± 6.2 < 0.01
Sex (M/F) 72/14 52/13 20/1 0.17 39/13 33/1 < 0.01
Lactate level (mg/dL) 36.5 ± 26.4 32.3 ± 22.7 49.7 ± 32.9 0.03 32.7 ± 24.1 42.3 ± 29.1 0.10
Sepsis diagnosis site 0.98 0.10
Emergency department 24 (27.9) 18 6 18 6
General ward 9 (10.5) 7 2 5 4
RICU 53 (61.6) 40 13 29 24
Cause of sepsis 0.10 0.52
Pneumonia 65 (75.5) 52 13 40 25
Biliary tract infection 9 (10.4) 6 3 6 3
Urinary tract infection 4 (4.7) 2 2 2 2
Bacteremia 4 (4.7) 3 1 2 2
Others 4 (4.7) 2 2 2 2
Comorbidity, n (n/N)
Diabetes mellitus 26 (30.2) 21 5 0.46 18 8 0.27
Chronic lung disease 28 (32.6) 20 8 0.53 17 11 0.97
Cerebrovascular accident 12 (14.0) 10 2 0.72 9 3 0.34
Cardiovascular disease 34 (39.5) 29 5 0.09 24 10 0.12
Chronic renal disease 10 (11.6) 6 4 0.25 5 5 0.47
Liver disease 10 (11.6) 7 3 0.70 7 3 0.73
Others 6 (7) 4 2 0.63 1 5 0.02
Outcome indicators
RICU LOS (d) 16.2 ± 11.8 20.3 ± 10.7 3.4 ± 1.7 < 0.01 20.5 ± 10.8 9.6 ± 10.2 < 0.01
Hospital LOS (d) 27.4 ± 20.0 33.3 ± 18.6 9.1 ± 11.2 < 0.01 35.8 ± 19.5 14.5 ± 12.7 < 0.01
*Data presented as n (%) or mean ± standard deviation. APACHE = Acute Physiology and Chronic Health Evaluation; M = male; F = female; RICU = respi-
ratory intensive care unit; LOS = length of stay.
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Statistical analysis
The data are expressed as mean ± standard devia-
tion or percentage. Categorical data were compared
using χ2 analysis with the Fisher exact test. Student’s
t test was used for continuous data analysis. Logistic
regression was applied for further comparison.
SPSS version 12.0 (SPSS Inc., Chicago, IL, USA)
was used to analyze the data. Statistical signifi-
cance was defined as p < 0.05.
Results
Initially, 114 suspected eligible patients were
screened. Fourteen of them had sepsis, but did
not meet the enrolment criteria. Fourteen of the
100 enrolled patients were excluded because of
late onset of severe sepsis (post 24 hours after
RICU admission). Finally, 86 patients were
treated with protocol-driven sepsis therapy. They
were aged 71.7 ± 14.2 years and predominantly
male (male/female, 72/14). The disease severity
was relatively high (APACHE II score, 25.0 ± 7.0)
and poor tissue perfusion status (plasma lactate
level, 36.5 ± 26.4 mg/dL) was noted. The most
common cause of sepsis was pneumonia (75.6%)
(Table 1). The average time of RICU bed avail-
ability was about 672 minutes for patients from
the general ward and ED (n = 33, Table 2). Resus-
citation was initiated around 107 ± 296 minutes
after the patients met the criteria for severe sepsis
or septic shock (a total of 86 patients). Compli-
ance with P1, P2, P4 and P6 was 73.4%, 80.6%,
91.8% and 78.9%, respectively. Protective ventila-
tor strategy was applied to all patients with an ini-
tial plateau pressure (0 hours at admission to the
RICU) < 30 cmH2O (24.5 ± 6.4 cmH2O) (Table 2).
Key structure and process-of-care indicators
associated with mortality
In terms of mortality at 7 days after admission to
the RICU, the structure indicators (APACHE II
score and plasma lactate level) (Table 1) and pro-
cess-of-care indicators (Ti-s, Tr-s and initial pla-
teau pressure) (Table 2) were significantly different
between the survival and mortality groups. The
Table 2. Process-of-care indicators for patients who received protocol-driven therapy*
RICU 7-day outcome RICU discharge outcome
Outcome All patients
Survival Mortality p Survival Mortality p
Patients 86 65 (75.6) 21 (24.4) 52 (60.5) 34 (39.5)
Elements
P1 (%) 73.4 75 68.4 0.57 76.00 95.7 0.49
P2 (%) 80.6 80 82.4 1.00 69.00 85.2 0.97
P4 (%) 91.8 94.7 81.3 0.11 80.5 73.7 0.18
P6 (%) 78.9 75.6 91.7 0.42 80.8 89.5 0.30
Ti-s (min) 672.5 ± 531.5 562.2 ± 483.3 1017.3 ± 557.8 0.03 588.0 ± 489.6 867.0 ± 598.5 0.17
(n = 33)† (n = 33) (n = 25) (n = 8) (n = 23) (n = 10)
Tr-s (min) 106.6 ± 295.6 60.7 ± 207.8 248.5 ± 453.1 0.07 83.1 ± 212.9 142.4 ± 391 0.26
Plateau pressure 24.5 ± 6.4 23.6 ± 5.6 27.1 ± 7.8 0.02 23.9 ± 5.9 25.4 ± 7.0 0.32
(cmH2O)
MAP (mmHg) 72.5 ± 14.5 73.0 ± 14.6 70.5 ± 14.5 0.53 73.3 ± 15.7 71.2 ± 12.7 0.56
CVP (cmH2O) 17.3 ± 6.9 16.7 ± 6.6 19.5 ± 7.9 0.13 17.5 ± 6.6 16.9 ± 7.6 0.72
SpO2 (%) 94.4 ± 7.6 95.5 ± 4.7 90.8 ± 12.8 0.14 95.6 ± 4.9 92.7 ± 10.2 0.10
ScvO2 (%) 71.4 ± 10.1 71.2 ± 10.1 72.0 ± 10.6 0.75 72.9 ± 9.4 68.9 ± 11.0 0.07
*Data presented as n (%) or mean ± standard deviation; †n = 33 for patients from the emergency department and general ward who developed severe 
sepsis prior to admission to the respiratory intensive care unit (RICU). Ti-s = RICU bed availability; Tr-s = resuscitation time; MAP = mean artery pressure;
CVP = central venous pressure; SpO2 = pulse oximeter oxygen saturation; ScvO2 = central venous oxygen saturation. The above values for MAP, CVP, SpO2
and ScvO2 represent the initial data recorded once the patient met the criteria for admission to the RICU.
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Table 3. Differences between early and late phase during implementation of protocol-driven therapy
Element Early phase Late phase p
Structure indicators
Patients 34 52
Age (yr) 72.9 ± 14.6 70.9 ± 14.3 0.54
APACHE II 25.3 ± 6.4 24.8 ± 7.3 0.72
Sex (M/F) 28/6 44/8 0.78
Lactate level (mg/dL) 31.1 ± 19.3 40.0 ± 29.9 0.09
Sepsis diagnosis site 0.89
Emergency department 8 (23.5) 16 (30.7)
General ward 6 (17.6) 3 (5.8)
RICU 20 (58.9) 33 (63.5)
Cause of sepsis 0.80
Pneumonia 26 (76.5) 39 (75.0)
Biliary tract infection 3 (8.8) 6 (11.6)
Urinary tract infection 2 (5.9) 2 (3.8)
Bacteremia 2 (5.9) 2 (3.8)
Others 1 (2.9) 3 (5.8)
Comorbidity
Diabetes mellitus 7 (20.6) 19 (36.5) 0.11
Chronic lung disease 15 (44.1) 13 (25.0) 0.06
Cerebrovascular accident 6 (17.6) 6 (11.5) 0.42
Cardiovascular disease 17 (50.0) 17 (32.7) 0.10
Chronic renal disease 5 (14.7) 5 (9.6) 0.47
Liver disease 3 (8.8) 3 (5.8) 0.73
Others 3 (8.8) 3 (5.8) 0.67
Process-of-care indicators
P1 (%) 72.4 74 0.87
P2 (%) 95.5 73.3 0.04
P4 (%) 96.2 89.4 0.41
P6 (%) 73.7 81.6 0.49
Ti-s (min) (n = 33) 448.3 ± 481.3 (n = 14) 837.7 ± 516.7 (n = 19) 0.03
Tr-s (min) 75.6 ± 249.2 126.8 ± 323.1 0.43
Plateau pressure (cmH2O) 25.1 ± 6.2 24.1 ± 6.5 0.49
MAP (mmHg)† 68.8 ± 10.2 75.0 ± 16.5 0.07
CVP (cmH2O)† 17.0 ± 7.3 17.4 ± 6.7 0.81
SpO2 (%)† 93.3 ± 8.7 95.2 ± 6.7 0.27
ScvO2 (%)† 66.9 ± 10.5 74.4 ± 8.8 < 0.01
Outcome indicators
RICU LOS (d) 18.4 ± 12.5 14.7 ± 11.2 0.16
Hospital LOS (d) 30.9 ± 21.0 25.1 ± 19.2 0.19
Mortality rate
RICU 7-day (%) 20.6 26.9 0.50
RICU discharge (%) 38.2 40.4 0.82
Hospital discharge (%) 47.1 44.2 0.79
*Data presented as n or mean ± standard deviation or n (%); †MAP, CVP, SpO2 and ScvO2 represent the initial data recorded once the
patient met the criteria for admission to the RICU. APACHE = Acute Physiology and Chronic Health Evaluation; M = male; F = female;
RICU = respiratory intensive care unit; Ti-s = RICU bed availability; Tr-s = resuscitation time; MAP = mean artery pressure; CVP = central
venous pressure; SpO2 = pulse oximeter oxygen saturation; ScvO2 = central venous oxygen saturation; LOS = length of stay.
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RICU bed availability (RICU waiting time; Ti-s)
for 33 patients from the ED and general ward was
significantly shorter in the survival group than in
the mortality group (562.2 ± 483.3 vs. 1017.3 ±
557.8 minutes, p = 0.03). In addition, early resus-
citation was related strongly to good prognosis.
Tr-s was longer in the mortality group than the
survival group (248.5 ± 453.1 vs. 60.7 ± 207.8
minutes, p = 0.07). When the initial ventilator
setting of plateau pressure was maintained at
<30 cmH2O, it seemed helpful for survival
(23.6 ± 5.6 vs. 27.1 ± 7.8, p = 0.02). With regard
to the RICU discharge outcome, APACHE II score
and sex both had a significant effect on survival.
The time interval was shorter in the survival
group (Ti-s, 588 ± 489.6 vs. 867.0 ± 598.5 min-
utes; Tr-s, 83.1 ± 212.9 vs. 142.4 ± 391 minutes).
The mortality rate at 7 days after RICU admission
and at RICU discharge was 24.4% and 39.5%, 
respectively. Using logistic regression, Tr-s was
the key process indicator for RICU 7-day and 
discharge mortality (p = 0.05; Table 4).
Comparison between early and late 
phase of implementing protocol-driven 
sepsis therapy
After we analyzed the early and late phase of pro-
tocol implementation, we found no difference in
the structure indicators. Among the process-of-care
indicators, P2, Ti-s and ScvO2 were all significant
(p = 0.04, 0.03 and < 0.01, respectively). There was
no significant difference between the two phases
in the outcome indicator (mortality at 7 days after
RICU admission, RICU discharge and hospital
discharge) (Table 3).
Discussion
In dealing with severe sepsis and septic shock,
the golden rule is early recognition and interven-
tion.5,16–18 Our data corroborated that early ini-
tiation of resuscitation can reduce RICU 7-day
mortality. It took a shorter time to start resus-
citation after recognizing severe sepsis or septic
shock in the survival group (60.7 ± 207.8 min-
utes) than the mortality group (248.5 ± 453.1
minutes). Lundberg et al reported that ICUs pro-
vide a quicker response to septic shock than gen-
eral wards.17 Delay in transferring septic shock
patients from wards to the ICU leads to high mor-
tality. According to their study, the mean delay
time was about 148 minutes from wards to the
ICU. This underlines the importance of ICU bed
availability in the management of severe sepsis
and septic shock. It might not only provide im-
mediate resuscitation, but also help maintain tis-
sue perfusion and intensive resuscitation. Our
Table 4. Logistic regression of key indicators for patients who received protocol-driven therapy
Key indicators Odds ratio 95% confidence interval p
RICU 7-day mortality
APACHE II 1.53 0.94–2.51 0.86
Lactate level (mg/dL) 0.96 0.86–1.07 0.52
Ti-s (min) 1.00 0.99–1.01 0.36
Tr-s (min) 1.01 1.00–1.02 0.05
Plateau pressure (cmH2O) 0.86 0.69–1.06 0.16
RICU discharge mortality
APACHE II 1.36 1.04–1.79 0.02
Lactate level (mg/dL) 1.01 0.95–1.08 0.66
Ti-s (min) 1.00 0.99–1.01 0.91
Tr-s (min) 1.01 1.00–1.01 0.05
Plateau pressure (cmH2O) 0.89 0.74–1.07 0.23
RICU = respiratory intensive care unit; APACHE = Acute Physiology and Chronic Health Evaluation; Ti-s = RICU bed availability; Tr-s =
resuscitation time.
study showed that early admission to the RICU
for further protocol implementation reduced the
mortality rate. There was less waiting time for
RICU beds in the survival group than in the mor-
tality group. Therefore, early diagnosis and timely
resuscitation (shorter Tr-s) along with intensive
care (ICU bed availability) under protocol guid-
ance are the way to ensure quality of care.3,12
The definition of T-sepsis was proven when
eligible patients had three major components:
SIRS; suspicious or documented infection; and tis-
sue hypoperfusion. Development of severe sepsis
evolves continuously. Clinical physicians should
be alert in identifying potential cases. If not, the
diagnosis of severe sepsis will be delayed. There-
fore, the T-sepsis measured by our protocol might
have a time lag compared with the time that 
T-sepsis actually developed. This was a limitation
of the process of clinical care. The values of Ti-s
and Tr-s were underestimated, but their trends
were clear. We should take action to shorten the
period to improve the outcome. The time lag did
not seem to compromise our conclusion.
In our study group, 53 patients met the enrol-
ment criteria within 24 hours after admission to
the RICU, and completed the protocol at the
RICU. Most of the patients were admitted to the
RICU via the ED. Why were they not enrolled at
the ED? One of the reasons was the dynamic pro-
cess of sepsis. In the ED, they did not meet the
protocol criteria, but developed septic shock when
admitted to the RICU. However, it was possible
that these patients did not receive sufficient at-
tention because of the lack of time and limited
staffing in the ED. Thus, the patients’ enrolment
criteria were not checked until they were admit-
ted to the RICU. It is necessary to monitor the
exact process when we manage such patients with
sepsis in the future.
The hospital mortality in our study was rela-
tively high (45%) compared with that in other
studies (30–40%).11,19 Reviewing some recent
studies of ICU-based sepsis therapy,11,19 we found
that patients with severe sepsis or septic shock
were screened at admission or during their stay
in the ICU. The definition of severe sepsis in the
Finnsepsis study was sepsis combined with acute
organ dysfunction,19 but we defined severe sepsis as
that with plasma lactate > 36 mg/dL, dysfunction
of more than one organ, or hypotension after
20 mL/kg fluid replacement. APACHE II scores
were higher in our study than in that of Rivers 
et al1 (25.0 ± 7.0 vs. 21.4 ± 6.9), and poor tissue
perfusion was found (mean plasma lactate level,
36.5 ± 26.4 mg/dL) (Table 1). These data sup-
ported our suspicion that the enrolment criteria
were too strict to identify patients with sepsis
and impending septic shock. It was necessary to
redefine the enrolment criteria and be alert to
screen the potential cases in the ED. Therefore,
enhancing awareness of sepsis and educating
health care personnel involved in the treatment
process can improve the survival rate, as stated
by Ferrer et al.11
Outcome is related to compliance with the sep-
sis protocol (sepsis bundles), but ours was not. The
mortality reduction rate for patients who complete
the protocol (sepsis bundles) is 20–26%.8,10 In a
study by Gao et al, all of the elements of the 6-
hour and 24-hour sepsis bundles were completed
in 52% and 30% of 101 consecutive sepsis patients,
respectively.8 Although the compliance rate did
not reach the target, the implementation of the
bundles reduced hospital mortality by 26% in
the compliance group for the 6-hour sepsis bun-
dle. In a study by Nguyen et al, five quality indi-
cators were proposed for the management of
severe sepsis patients in the ED.10 Fifty-one per-
cent of the patients received complete bundle
therapy. The mortality rate was lower for patients
with completed bundles than for those without
(20.8% vs. 39.5%). A nationwide survey con-
ducted in Spain by Ferrer et al has shown that
only 10% of the patients received a complete re-
suscitation bundle, which comprised six tasks
within 6 hours, and 15.7% finished the manage-
ment bundle that consisted of four tasks within
24 hours.11 In contrast to compliance with whole
bundles in the previous studies,8,10,11 we sepa-
rated our protocol into P1, P2 and P4 according
to the time course. Compliance with P6 denoted
not only finishing the tasks, but also reaching the
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targets at 6 hours after enrolment. However, we
did not find any significant difference between
survival and mortality groups for P1, P2, P4 or
even P6. Our compliance rate for the process-
of-care indicators was 70–90%, which is higher
than previously reported.8,10,11 Compliance did
not significantly affect mortality at 7 days after
RICU admission or at RICU discharge. This might
be because of the small number of cases or the
severity of the underlying disease (high APACHE
II score and high level of lactate).
Between the early and late phase of our study,
there was no difference in the structure indicators
(Table 3). This represents consistency of disease
severity and complexity of the whole protocol-
performing phase. Among process-of-care indi-
cators, although compliance with P2 was higher
in the early phase (95.5% vs. 73.3%, p = 0.04),
there was no significant change in the mortality
at 7 days after RICU admission, RICU discharge
or hospital discharge. In addition, we found acci-
dentally that ScvO2 was higher in the late phase
of our study. We need a larger number of cases
than in the present study to identify the clinical
effect of this finding. The low P2 in the late phase
of our study could have been attributed to the
overload of clinical care in the winter (October
to February). Not all of the details of P2 could be
finished within the allotted time (2 hours). RICU
overload was also responsible for the longer wait-
ing time for RICU bed availability (Ti-s) in the
late phase. The number of cases of respiratory-
tract-infection-related pneumonia increased dur-
ing that period, therefore, admission time was
longer.
Among the process-of-care indicators, venti-
lator setting played an important role. The major
cause of sepsis in our patients was pneumonia. 
It progressed readily to sepsis and acute respira-
tory distress syndrome. Therefore, protective ven-
tilatory strategy with high positive end-expiratory
pressure, low tidal volume and target plateau
pressure < 30 cmH2O are the norm.2,15,20–26 All
of our patients had an initial plateau pressure 
(0 hours at admission to the RICU) of no more
than 30 cmH2O. We found a lower initial plateau
pressure (23.6±5.6 vs. 27.1±7.8 cmH2O, p=0.02)
in the survival group for 7-day RICU outcome.
Such pressure also might be caused by the severity
of underlying disease. To date, no definite evidence
has shown that the initial plateau pressure can
predict patient outcome. Further study is needed
to determine the significance of these results.
Limitations of our study
Our patient number (n = 86) was too small to
represent the complete spectrum of severe sepsis
and septic shock. A larger group of patients is
needed for further evaluation of the protocol.
Furthermore, our retrospective study might not
reflect the performance of our protocol in real
time. We need to design a prospective study to
determine further the effectiveness of protocol
implementation.
In conclusion, our protocol-driven sepsis ther-
apy is a continuous quality improvement process.
After 1 year of implementation, we reviewed the
key structure and process-of-care indicators. The
technique of resuscitation was done well (com-
pliance with P1, P2, P4 and P6 was > 70%). Diag-
nostic criteria for aggressive fluid resuscitation
should be redefined to cover patients with sepsis
and impending septic shock. When the ED is
limited in the period of early resuscitation, the
ICU should be available as soon as possible to
maintain early resuscitation. We plan to adjust
the indicators involved in clinical practice to im-
prove the outcome of severe sepsis in our hospi-
tal. Here, we provide valuable and key process
indicators for the treatment of severe sepsis.
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